FFA
CLDI icon

Farther Finance Advisors’s Calidi Biotherapeutics CLDI Stock Holding History

Farther Finance Advisors’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7K Hold
10,000
– – ﹤0.01% 5213
2026
Q1 		$2.43K Hold
10,000
– – ﹤0.01% 4826
2025
Q4 		$11.7K Buy
+10,000
New +$14.7K ﹤0.01% 3802

Other funds holding CLDI

RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Farther Finance Advisors's CLDI Position: Q2 2026 in Review

Farther Finance Advisors held its Calidi Biotherapeutics (CLDI) position steady in Q2 2026 at 10,000 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5213.

Farther Finance Advisors first reported a position in CLDI in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.7K in Q4 2025. 3 funds tracked by Wall St. Rank hold CLDI as of Q2 2026.

  • Farther Finance Advisors held 10,000 shares of Calidi Biotherapeutics worth $1.7K as of Q2 2026.
  • Farther Finance Advisors left its Calidi Biotherapeutics share count unchanged in Q2 2026.
  • Calidi Biotherapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5213 holding.
  • Farther Finance Advisors first reported a position in Calidi Biotherapeutics in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Calidi Biotherapeutics position peaked at $11.7K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.